Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Feb 5, 2026, 16:20
Emmanuel J Favaloro: New Study on Biomarkers for Coagulation Disorders
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomolecules (MDPI):
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis. Again ably led by Ben Reardon. Biomarkers of Coagulation Disorders.”
Title: Biomarkers of Coagulation Disorders—Where to from Here?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Read the Full Article on Biomolecules (MDPI)
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Mar 22, 2026, 17:21Arrigo Francesco Giuseppe Cicero: Diagnostic and Prognostic Perspectives of Glycocalyx Disruption in Pregnancy
-
Mar 22, 2026, 17:19Veronica Sanchez: Stress from Pregnancy Complications Impacts The Long-Term Cardiovascular Health
-
Mar 22, 2026, 16:21Ala Eddin Sagar: Apixaban vs Rivaroxaban on This Week in Pulmonary and Critical Care Medicine
-
Mar 22, 2026, 16:14Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
-
Mar 22, 2026, 16:03Fibrinogen-Guided Management of Postpartum Hemorrhage – Transfusion Medicine KMC Manipal
-
Mar 22, 2026, 15:48Simon Senanu: Diagnostic Significance of Target Cells in Peripheral Blood Smear
-
Mar 22, 2026, 15:43Hayley Evans: What If The Decision Support System Is Part of The Problem?
-
Mar 22, 2026, 15:29Archit Pandharipande: The Burden and Impact of Heavy Menstrual Bleeding in Adolescents with Bleeding Disorders
-
Mar 22, 2026, 15:17Mamtha Balla: Mastering the Lab and Clinical Connection in Hemostasis and Thrombosis